Sir Andrew Dillon has led the organisation for 20 years.
News
Skyrizi bags NICE fast-track
Eligible patients in England and Wales will have access to the drug almost two months earlier.
GSK HIV combo meets main goal in Phase III study
The drug could now be administered every eight weeks compared to every four.
Scottish charity calls on minister to ‘curb obesity crisis’
The letter urges for regulation to restrict price promotions on food and drink products high in fat, sugar and salt.
Richter launches Forsteo biosimilar in EU
Both products are approved in adults for osteoporosis in various indications.
£708,000 granted for fertility research
The injection was made as the last two decades have witnessed dramatic, unpredicted changes in fertility levels.
NHS to reimburse Hemlibra
The ‘life-changing’ drug will be reimbursed for certain people with severe congenital haemophilia A.
AZ’ Imfinzi combo fails lung cancer study
The drug giant reported that in the primary analysis population the combination did not meet the primary endpoint.
Finals day location confirmed for the 2019 Sales Awards
IQVIA have been confirmed to host the head-to-head finals day at their offices based in Reading on the 26th of September.
‘Unhappy’ pupils more likely to be smokers and drinkers
The report also revealed that 2% of pupils had recently smoked, drunk alcohol and taken drugs and 11% had done only one of these recent behaviours.
Sarepta’s DMD drug hit with FDA Complete Response Letter
The company say they are “surprised” to have received the letter.
£3.3m boost for mental illness in children
The funding comes as part of the government’s commitment to transforming mental health care.
Positive results continue success for Forxiga
Forxiga has had a string of successes recently, as it was recommended by NICE and had its EU marketing authorisation updated earlier this month.
Nationwide sepsis push saves ‘hundreds of lives’
The drive includes a one-hour identification and treatment ambition, as well as a new ‘alert and action’ technology.
Alzheimer’s charity launches mass survey
Alzheimer’s is a complex disease with lots of failed treatments in past pipelines.
